| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/07/2013 | WO2013032012A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | WO2013032011A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | WO2013031833A1 Skin introduction system and lightening agent combining cell introduction peptide and skin introduction accelerator |
| 03/07/2013 | WO2013031620A1 Osteogenesis promoter and use thereof |
| 03/07/2013 | WO2013030725A1 Methods for treating cardiovascular disorders |
| 03/07/2013 | WO2013030409A1 Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
| 03/07/2013 | WO2013030302A1 Protein complex comprising mcm8 and mcm9 proteins and their use |
| 03/07/2013 | WO2013030208A1 Cyclosporin derivatives |
| 03/07/2013 | WO2013030160A1 Pharmaceutical combination for use in glycemic control in diabetes type 2 patients |
| 03/07/2013 | WO2013030111A1 Structural mimetics of proline-rich peptides and use thereof |
| 03/07/2013 | WO2013029627A1 Compositions and methods for treating or preventing radiation- or chemotherapy-induced pulmonary dysfunction |
| 03/07/2013 | WO2013029616A1 Pet tracer for imaging of neuroendocrine tumors |
| 03/07/2013 | WO2013029279A1 Novel glp-i analogue, preparation method and use thereof |
| 03/07/2013 | WO2013029205A1 Cleavable protein of interferon fused with human serum albumin and encoding gene and use thereof |
| 03/07/2013 | WO2013029182A1 Stable peptide-based furin inhibitors |
| 03/07/2013 | WO2013029180A1 Stable peptide-based pace4 inhibitors |
| 03/07/2013 | WO2013010028A3 COMPOSITIONS AND METHODS FOR IMPROVED CaMKII INHIBITORS AND USES THEREOF |
| 03/07/2013 | WO2013009690A3 Leukemia stem cell targeting ligands and methods of use |
| 03/07/2013 | WO2013009627A3 Factor viii chimeric and hybrid polypeptides, and methods of use thereof |
| 03/07/2013 | WO2013007704A3 Novel sdf-1-based glycosaminoglycan antagonist and methods of using same |
| 03/07/2013 | WO2013002531A9 Pharmaceutical composition for treating scars on the skin, and method for treating scars on the skin using same |
| 03/07/2013 | WO2012169735A3 Complex comprising water-soluble fragments of fcεri and composition comprising same for treating allergic diseases mediated by ige |
| 03/07/2013 | WO2012160333A3 Recombinant yeast expressing human h- ferritin |
| 03/07/2013 | WO2012138919A9 Method of treating or ameliorating metabolic disorders using growth differentiation factor 15 (gdf-15) |
| 03/07/2013 | US20130061341 Meganuclease variants cleaving a dna target sequence from a xp gene and uses thereof |
| 03/07/2013 | US20130060208 Wound care products |
| 03/07/2013 | US20130059800 Pyrrolobenzodiazepines used to treat proliferative diseases |
| 03/07/2013 | US20130059799 Aromatic-cationic peptides and uses of same |
| 03/07/2013 | US20130059798 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway |
| 03/07/2013 | US20130059797 Linaclotide for the Treatment of Chronic Constipation |
| 03/07/2013 | US20130059796 Cyclosporin compositions |
| 03/07/2013 | US20130059795 Novel Composition Of Matter For Delivering Lipid-Soluble Materials, And A Method For Producing It |
| 03/07/2013 | US20130059794 Alpha-fetoprotein "ring and tail" peptides |
| 03/07/2013 | US20130059793 Egf receptor mimicking peptides |
| 03/07/2013 | US20130059792 Traceability of Cellular Cycle Ano |
| 03/07/2013 | US20130059791 Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium slat of d-isoglutamyl-d-tryptophan |
| 03/07/2013 | US20130059790 Process for the preparation of a biomass comprising plantaricin and uses thereof in medical field |
| 03/07/2013 | US20130059789 Method for Treating Premature Ejaculation With a Botulinum Neurotoxin |
| 03/07/2013 | US20130059788 Prodomain modulators of adam 10 |
| 03/07/2013 | US20130059787 Methods of using human protein kinase c delta viii as a biomarker |
| 03/07/2013 | US20130059786 Compositions and methods for the treatment of cardiac and vascular disease |
| 03/07/2013 | US20130059785 Gene and Polypeptide Sequences |
| 03/07/2013 | US20130059784 Combination therapies using cyclosporine and aromatic cationic peptides |
| 03/07/2013 | US20130059783 Compositions and methods for expanding bfu-e cells |
| 03/07/2013 | US20130059782 Phospholipid-enriched vesicles bearing tissue factor having haemostatic activities and uses thereof |
| 03/07/2013 | US20130059781 Long-Acting Gastrin Derivatives |
| 03/07/2013 | US20130059780 Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1] |
| 03/07/2013 | US20130059779 Stabilized Insulin-like Growth Factor Polypeptides |
| 03/07/2013 | US20130059778 Identification of a Genetic Risk Factor for Diabetes |
| 03/07/2013 | US20130059777 Modulation of glucose-6-phosphatase translocase expression |
| 03/07/2013 | US20130059776 Antiviral Cell-Penetrating Peptides |
| 03/07/2013 | US20130059775 Nucleic Acid Complexes |
| 03/07/2013 | US20130059774 Efflux pump inhibitors |
| 03/07/2013 | US20130059773 Compounds for the treatment of inflammation and neutropenia |
| 03/07/2013 | US20130059772 Use of Repeat Sequence Protein Polymers in Personal Care Compositions |
| 03/07/2013 | US20130059771 Function and Regulation of Angiopoietin-3/Angiopoietin-4 |
| 03/07/2013 | US20130059770 Polypeptides |
| 03/07/2013 | US20130059769 Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications |
| 03/07/2013 | US20130059768 Lipid compositions with high dha content |
| 03/07/2013 | US20130059752 Compositions and methods for the treatment of immune related diseases |
| 03/07/2013 | US20130059382 Biomedical materials for tissue engineering |
| 03/07/2013 | US20130059337 Therapeutic Uses of Humanized Antibodies Against ALPHA-4 Integrin |
| 03/07/2013 | US20130059020 Cosmetic active ingredient preparation for increasing the long-term epidermal vitality of the skin |
| 03/07/2013 | US20130059008 Drying methods for tuning microparticle properties |
| 03/07/2013 | US20130059001 Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same |
| 03/07/2013 | US20130059000 Oral delivery for hemoglobin based oxygen carriers |
| 03/07/2013 | US20130058999 Pharmaceutical compositions for oral administration of insulin peptides |
| 03/07/2013 | US20130058994 Liposomes containing oligopeptide fragments of myelin basic protein, a pharmaceutical composition and a method for treatment of multiple sclerosis |
| 03/07/2013 | US20130058993 Methods and compositions for enhancing wound healing using car peptides |
| 03/07/2013 | US20130058992 Gene expression signatures associated with response to imatinib mesylate in gastrointestinal stromal tumors and use thereof for predicting patient response to therapy and identification of agents which have efficacy for the treatment of cancer |
| 03/07/2013 | US20130058991 Matricryptic ecm peptides for tissue reconstruction |
| 03/07/2013 | US20130058983 Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses |
| 03/07/2013 | US20130058969 Chloroplasts engineered to express pharmaceutical proteins |
| 03/07/2013 | US20130058950 Methods for detecting progenitor cells and uses thereof |
| 03/07/2013 | US20130058940 Novel Gene And Protein Associated With Angiogenesis And Endothelial Cell Specific Apoptosis |
| 03/07/2013 | US20130058939 Treatment of neurological or neurodegenerative disorders |
| 03/07/2013 | US20130058928 Hair growth methods using fgfr3 extracellular domins |
| 03/07/2013 | US20130058926 Method for alleviating and/or preventing skin reddening |
| 03/07/2013 | US20130058915 Methods and compositions for treatment of angelman syndrome and autism spectrum disorders |
| 03/07/2013 | US20130058914 Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof |
| 03/07/2013 | US20130058913 Lactase Formulations |
| 03/07/2013 | US20130058912 Therapeutic Charge Engineered Variants of Lysozyme and Methods for Using Same to Treat Infections |
| 03/07/2013 | US20130058911 Reducing agent from microorganism belonging to genus bacillus and application for same |
| 03/07/2013 | US20130058908 High affinity ny-eso t cell receptors |
| 03/07/2013 | US20130058906 Process, tube and device for the preparation of wound healant composition |
| 03/07/2013 | US20130058904 Method and system for treatment of biological tissue |
| 03/07/2013 | US20130058896 Compositions and methods related to anti-fgf agents |
| 03/07/2013 | US20130058895 High Pressure Treatment of Aggregated Interferons |
| 03/07/2013 | US20130058894 Therapeutic protein-specific induced tolerogenic dendritic cells and methods of use |
| 03/07/2013 | US20130058893 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 03/07/2013 | US20130058892 Pyrimidinyl indole compounds |
| 03/07/2013 | US20130058891 Kexin-Derived Vaccines to Prevent or Treat Fungal Infections |
| 03/07/2013 | US20130058880 Film forming personal care compositions and methods |
| 03/07/2013 | US20130058873 P97 fragments with transfer activity |
| 03/07/2013 | US20130058871 Method and system for mapping synaptic connectivity using light microscopy |
| 03/07/2013 | US20130058869 Prevention And Treatment Of Amyloidogenic Disease |
| 03/07/2013 | DE112011100556T5 Gering hämolytisches antimimikrobielles Peptid, dessen pharmazeutische Zusammensetzung und Verwendung Low hemolytic antimimikrobielles peptide whose pharmaceutical composition and use |
| 03/07/2013 | CA2847527A1 Bmp peptides & methods of use |
| 03/07/2013 | CA2847336A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | CA2847334A1 Glycosylated polypeptide and drug composition containing said polypeptide |